Clinical Trials on Squamous Cell Carcinomas in Switzerland

Total 950 results

Andreas Hottinger
Ecole Polytechnique Fédérale de Lausanne

Unknown

Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model (XENOGBM)

Glioblastoma

Switzerland
Novartis

Completed

Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients

Metastatic Melanoma

Switzerland
AstraZeneca

Active, not recruiting

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) (MYSTIC)

Non-Small-Cell Lung Carcinoma NSCLC

United States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
ETOP IBCSG Partners Foundation
Bristol-Myers Squibb; Intergroupe Francophone de Cancerologie Thoracique; Frontier... and other collaborators

Unknown

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease (STIMULI)

Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer

Switzerland, France, Spain, Germany, United Kingdom, Netherlands, Australia, Belgium
Lymphoma Study Association
Fondation ARC

Terminated

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Switzerland, Belgium
Centre Hospitalier Universitaire Vaudois

Completed

Immunotherapy of Melanoma Patients

Melanoma

Switzerland
Reinhard Dummer

Completed

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma (TUPRO)

Melanoma

Switzerland
ETOP IBCSG Partners Foundation
European Organisation for Research and Treatment of Cancer - EORTC; Amgen

Terminated

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy (SPLENDOUR)

Lung Cancer Non-small Cell Stage IV

Ireland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
Hôpital Fribourgeois

Recruiting

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (BAZE)

Pancreas Cancer

Switzerland
University of Zurich

Recruiting

Response Assessment During MR-guided Radiation Therapy for Glioblastoma (MARGA)

Glioblastoma Multiforme

Switzerland
Kantonsspital Winterthur KSW

Unknown

Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study

Peritoneal Carcinomatosis

Switzerland
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of Stage III/IV Melanoma Patients

Melanoma

Switzerland
University of Zurich

Withdrawn

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Adenocarcinoma | Stomach Cancer | Cancer of Esophagogastric Junction

Switzerland
AstraZeneca

Completed

Iressa Versus Docetaxel (Taxotere)

Non-Small-Cell Lung Carcinoma

United States, Croatia, Sweden, Italy, Mexico, Spain, Turkey, Germany, Philippines, Malaysia, China, Estonia, Latvia, Hong Kong, Argentina, Belgium, Canada, Denmark, France, Indonesia, Thailand, Brazil, Switzerland, Singapore, Slovenia
University of Zurich
Swiss National Science Foundation

Recruiting

Glutamate Inhibitors in Glioblastoma (GLUGLIO)

Glioblastoma

Switzerland
University Hospital, Basel, Switzerland

Completed

Melanoma Detection in Switzerland With VECTRA (MELVEC)

Melanoma (Skin)

Switzerland
University Hospital, Basel, Switzerland
GMP network of Basel

Completed

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma (BaseTIL)

Advanced Melanoma

Switzerland
University Hospital, Geneva

Active, not recruiting

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma (IMA950-106)

Glioblastoma Multiforme | Glioblastoma Multiforme of Brain | Glioma of Brain | Glioblastoma, Adult

Switzerland
University of Lausanne Hospitals

Completed

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Carcinoma, Hepatocellular | Alcoholic Cirrhosis | Viral Cirrhosis | Postoperative Hepatic Failure

Switzerland
Novartis Pharmaceuticals

Completed

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States, Canada, France, Italy, Spain, Belgium, Germany, Hungary, Saudi Arabia, Netherlands, Switzerland, Australia, Austria, Poland, Sweden, United Kingdom, Thailand, Korea, Republic of, Greece, Israel, Argentina, Japan, Colo... and more
University Hospital, Basel, Switzerland
ETH Zurich - The Aceto Lab

Completed

Digoxin Induced Dissolution of CTC Clusters

Breast Cancer | Circulating Tumor Cells (CTCs)

Switzerland
University of Zurich

Completed

Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research

Recurrent Glioblastoma

Switzerland
University Hospital, Basel, Switzerland

Completed

DOTA-TOC in Metastasized Neuroendocrine Tumors

Neuroendocrine Tumors

Switzerland
University Hospital, Basel, Switzerland
University Hospital Inselspital, Berne; Luzerner Kantonsspital; University Hospital...

Terminated

Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner (TOGETHER)

Neoplasms | Glioblastoma

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients (TreoMel)

Multiple Myeloma

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

Chemotherapy and G-CSF for Mobilization (MOCCCA)

Multiple Myeloma

Switzerland
University Hospital, Geneva
Oncovir, Inc.; Immatics Biotechnologies GmbH

Completed

Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

CNS Tumor, Adult

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
University of Zurich

Completed

Retinal Ganglion Cell Layer in Patients With Intracerebral Processes

Ganglion Cells

Switzerland
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Lung Cancer

Spain, Netherlands, Belgium, Egypt, South Africa, Germany, Switzerland, France, Poland, Italy, Czech Republic, Greece
Hoffmann-La Roche

Completed

A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)

Non-Small Cell Lung Cancer

Spain, France, Germany, Switzerland, China, Turkey, Denmark, Egypt, Netherlands
Amgen

Recruiting

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Extensive Stage Small Cell Lung Cancer

Korea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
University Hospital, Geneva
European Society for Blood and Marrow Transplantation

Recruiting

Polymorphisms and Busulfan Pharmacokinetic Study

Children Who Receive a Stem Cell Transplantation With Busulfan IV

Canada, France, Switzerland
University of Zurich

Terminated

Hypertension Monitoring in Glioma Patients Treated With Bevacizumab

Glioma Patients

Switzerland
ETOP IBCSG Partners Foundation
Biodesix, Inc.

Completed

Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. (EMPHASIS)

Carcinoma, Non-Small-Cell Lung

Ireland, Switzerland, Denmark, Spain, United Kingdom, Belgium, Hungary, Greece, Israel, Austria, Italy, Netherlands
NovoCure Ltd.

Unknown

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Pancreatic Adenocarcinoma

Spain, Switzerland
AstraZeneca

Recruiting

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment (SAFFRON)

Carcinoma | Non-Small-Cell Lung

China, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Malaysia, Argentina, Hong... and more
University Hospital Inselspital, Berne
Mundipharma Medical Company

Completed

Bendamustine and Melphalan in Myeloma (BEB-2)

Multiple Myeloma

Switzerland
University Hospital Inselspital, Berne

Completed

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma (PAV)

Myeloma

Switzerland
Philogen S.p.A.

Completed

Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse (GLIOMOON)

Glioma of Brain

Switzerland
University Hospital, Geneva
Bayer

Completed

Sorafenib in Newly Diagnosed High Grade Glioma

Glioblastoma | Gliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

Switzerland
Amgen

Recruiting

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

Small Cell Lung Carcinoma

United States, Spain, Austria, Switzerland, United Kingdom, France, Australia, Germany, Japan, Taiwan, Poland, Hong Kong, Netherlands
Bayer

Completed

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma (FORT-1)

Carcinoma, Transitional Cell

United States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
Iovance Biotherapeutics, Inc.

Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Metastatic Non Small Cell Lung Cancer

United States, Canada, Germany, Netherlands, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

Non-Hodgkin Lymphoma

Switzerland
University of Zurich
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab for Newly Diagnosed Glioblastoma (PERGOLA)

Newly Diagnosed Glioblastoma

Switzerland
Amgen

No longer available

Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma

Unresected Stage IIIB to IVM1c Melanoma

Switzerland
NovoCure Ltd.

Unknown

Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)

Ovarian Carcinoma

Switzerland, Belgium, Germany, Spain
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME

Recruiting

Patient-derived Organoids Drug Screen in Pancreatic Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas Adenocarcinoma | Pancreas Cancer | Pancreas Neoplasm

Switzerland
Stiftung Swiss Tumor Institute
Klinik Hirslanden, Zurich; Manja Gideon Foundation

Terminated

The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer (ECOvar)

Ovarian Neoplasms | Patient Reported Outcome Measures

Switzerland

Clinical Trials on Squamous Cell Carcinomas in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations